The International Food and Food Additives Show (IFT FIRST) concluded successfully in Chicago in July 2025. As the world's largest and most influential annual event in the field of food science and technology, IFT brings together renowned food companies, research institutions, and industry leaders from around the globe, focusing on food innovation, safety, and sustainable development. It serves as a core platform for understanding cutting-edge industry trends and connecting global value chains.Shengtai Pharmaceutical participated in this year's IFT, showcasing multiple products and innovative solutions. The company demonstrated its R&D capabilities and product quality in the food and food additives field to international customers. The booth attracted the attention of numerous international clients and partners, who stopped to engage in in-depth discussions on product applications, market demands, and cooperation opportunities.Through this exhibition, the company further deepened its international business layout. Through interactions with global clients, the company accurately grasped international market dynamics and customer needs, reaching preliminary cooperation intentions with several potential clients, laying a solid foundation for expanding into overseas markets. This not only enhanced the company's brand influence in the international market but also accumulated valuable experience for future in-depth cooperation with international partners.Looking ahead, the company will continue to be customer-centric, increase investment in research and development, and launch innovative products. The company will actively participate in more international industry events, further cultivate the international market, and propel its brand onto a broader global stage, contributing to the development of the global food and related industries.
The crisp autumn air and the fragrant harvest heralded the arrival of autumn. To enrich the cultural life of employees, to unite "professional strength" through sports competitions, to "help the future" through teamwork, and to showcase the positive spirit of Shengtai employees, the first Staff Sports Meet, themed "Professional Strength, Helping the Future," was grandly held on September 27th and 28th. All employees enthusiastically participated, sweating and striving on the field, integrating professional spirit into every competition, and writing a chapter of pursuing dreams through unity and cooperation.First Day of Competition: Passion Ignites on the Track and Field, Fun Events Bring JoyOn the morning of September 27th, the opening ceremony of the Sports Meet was simple yet grand. Accompanied by the rousing athletes' march, teams from various departments entered the stadium in orderly formation. The athletes, full of spirit and shouting slogans like "Professionalism builds strength, hard work creates the future" and "Unity and spirit showcase style, working together to move forward," vividly interpreted the theme of "Professional Strength, Aiding the Future" and fully demonstrated the excellent spirit of Shengtai Pharmaceutical employees. After the opening ceremony, various sports events commenced. Athletes, relying on pre-planned tactics and unwavering will, marched step by step towards the finish line, echoing the theme with their spirit of never giving up.The spirit of sports will be passed down forever, uniting strength to forge a new journey. After two days of intense competition, the first "Professional Strength, Aiding the Future" Staff Sports Meet concluded successfully amidst laughter and joy.The successful hosting of this Staff Sports Meet not only provided employees with a platform to showcase themselves and unleash their energy, but also deeply ingrained the concept of "Professional Strength, Aiding the Future" in everyone's hearts, enhanced communication and cooperation among employees, and strengthened team cohesion. In the future, all employees will transform the professionalism, fighting spirit, and teamwork they displayed on the field into concrete actions that drive the company's high-quality development. With greater enthusiasm, higher morale, and a more professional attitude, they will dedicate themselves to their work, working together to contribute to the company's bright future!
With an annual corn processing capacity of 700,000 tons, and products covering five major sectors including pharmaceutical raw materials and food additives, its products are exported to over 70 countries and regions. Foreign trade has become the company's core growth engine. As a manufacturing champion holding multiple international certifications such as the US FDA and EU CEP, Weifang Shengteng Pharmaceutical Co., Ltd. (hereinafter referred to as "Shengteng Pharmaceutical") is providing a vivid example of traditional manufacturing companies "going global" through a dual-engine approach of "unreplicable technology + comprehensive certification coverage."International certifications are the "golden key" for Shengteng Pharmaceutical to unlock the global market. Facing the technical barriers and cultural differences of different countries, the company has built a certification system covering both pharmaceuticals and food: in the pharmaceutical field, it has obtained US DMF registration, EU CEP registration, Japanese JDMF registration and pharmaceutical GMP certification, and US FDA certification, among other pharmaceutical registration certifications; in the food field, it has obtained multiple certifications such as FSSC22000, HALAL, and KOSHER, allowing its products to smoothly enter markets with different religious beliefs and consumer needs. These certifications are not merely qualifications, but rather hard currency for the company to integrate into the global supply chain, laying a solid foundation for its market layout in 70 countries.Research and development innovation has built an "unreplicable" barrier to enhance the company's competitiveness in foreign trade. The company has two major R&D centers, three provincial-level and four municipal-level R&D platforms, and 64% of its 62 full-time R&D personnel hold master's degrees. It has accumulated 64 authorized patents and edited 23 enterprise standards. "Modified starch uses a special process, a technology that is unreplicable and has become one of the company's core competitive advantages," said Cui Hongbo. The current capacity of modified starch is 90,000 tons, which will reach 200,000 tons after expansion, making it the largest in the country and holding over 70% of the national market share after the expansion. In addition, some key indicators of injectable glucose are among the best in the domestic industry, making it a flagship product in overseas pharmaceutical markets, forming a "star product driving the entire line" foreign trade pattern.Deep channel cultivation makes foreign trade growth more resilient. Adhering to the concept of "going global, going deep into the market, and connecting with others," the company has created a linkage model of "exhibition-driven traffic generation + door-to-door outreach." By participating in international exhibitions such as CPHI Europe and IFT Food Ingredients in the US, the company has built communication platforms and solidified its cooperation foundation through targeted customer visits, significantly improving market expansion efficiency and enabling its corn deep-processed products to gradually enter the mainstream global supply chain from 30 provinces in China.Looking to the future, capacity upgrading and product optimization are key to expanding foreign trade. "We need to further strengthen the competitive advantage of our core products while promoting other products to achieve the same market position as our star products, thereby increasing our market share nationwide and even globally," said Cui Hongbo. He added that production line and technology optimization are crucial to achieving this goal. Currently, the company has planned three major projects: a 100,000-ton specialty corn starch project with a total investment of 200 million yuan, a 150,000-ton premium starch sugar project with a total investment of 400 million yuan, and a 220,000-ton high-end starch premix intelligent manufacturing project with a total investment of 300 million yuan. These three projects, with a total investment of 900 million yuan, will generate an additional 4.1 billion yuan in sales revenue upon completion, injecting new momentum into foreign trade growth.The company is breaking down market barriers with international certifications, building a competitive moat with unreplicable technologies, and consolidating its market share through precise channel cultivation. In today's increasingly competitive global market, this company, rooted in the corn deep processing industry, is promoting "Made in China" raw materials and auxiliary materials to a broader global stage through technological iteration and capacity upgrades.
Recently, Weifang Shengtai Medicine Co,Ltd. was interviewed by provincial media, introducing its international certification system, R&D innovation and overseas market layout. With authoritative certifications such as FDA and CEP, our products are exported to more than 70 countries and regions.The company’s high-end corn deep-processing projects are progressing steadily, focusing on special starch, refined starch sugar and pharmaceutical excipients. These projects will optimize product structure and boost high-quality development.Weifang Shengtai Medicine Co,Ltd.successfully won the bid for centralized procurement of large domestic pharmaceutical enterprises, becoming a core raw material supplier. It further consolidates our market position in pharmaceutical excipients.Committed to R&D and innovation, we continuously provide customized and high-quality products. We actively participate in international exhibitions including IFT and CPHI to expand global market and enhance brand influence.
Growing up in a small town with farmland stretching as far as the eye could see, I began to appreciate the importance of grains in our daily lives. Corn, especially, showed up everywhere: baked into breads, processed into feed, sometimes distilled into drinks shared at family gatherings. So, it’s striking to see how companies like Weifang Shengtai Medicine have taken this humble crop and transformed it into a backbone for global trade, with a focus on high-quality corn starch. Their journey isn’t just about tapping into a growing market; it’s about raising the bar. Corn starch does not get much attention in mainstream news, but people in manufacturing, food processing, pharmaceuticals, and even paper-making rely on this product every single day. Consistency in quality dictates factories’ efficiency and impacts workers’ livelihoods across continents. In a world where shelf lives, product textures, and cost management matter, quality standards in corn starch define who gets to compete on the world stage. Shengtai’s emergence as a trusted brand reflects their relentless attention to sourcing, processing technology, and supply reliability—factors that deliver value far beyond the usual cost-per-ton calculation.International supply chains have taken some hard knocks recently, from unpredictable harvests to shipping bottlenecks. What Weifang Shengtai brings to the table is a commitment to reliability. For a business partner, this counts. Factories switching between suppliers because of inconsistent batches soon realize the hidden costs: machines slow down, recipes miss their marks, even regulatory challenges grow, especially for exports heading into the European Union and North America. By maintaining strict controls from crop selection through to final shipment, Shengtai’s operation serves as a model for how agri-processing can build long-term partnerships. Their ability to deliver on schedule and in massive volumes isn’t just a testament to modern logistics; it benefits customers who cannot afford second guesses in their critical production cycles. Reports from multinational food producers highlight that trusted suppliers keep production lines humming and reduce expensive product recalls. Their focus on food safety helps prevent disruptions for everyone from family-owned bakeries to international packaged food brands.From my own experience talking with local farmers and mill operators, economic development often runs up against difficult questions: will new factories absorb rural labor, or will they push people aside? Shengtai’s story offers a refreshing alternative. Their approach includes working closely with farmers, guaranteeing purchase contracts, and fostering knowledge exchange. In practical terms, this can mean more stable incomes for farmers, lower risk from price swings, and increased incentives to use sustainable methods. By backing up their promises with actions, Shengtai sets a standard for others. Strong relationships with local suppliers fuel both agricultural resilience and environmental care. Responsible sourcing and supporting good agricultural practices boost both soil health and regional employment. Moreover, when manufacturers minimize waste, invest in water-saving technology, and cut emissions, progress touches more than just profit margins. These operations help prevent soil depletion and keep waterways cleaner for everyone living nearby. As consumers increasingly seek out environmentally aware brands, Shengtai’s approach builds trust and widens their international reach.Having seen small-scale food processors struggle with quality issues due to poor raw materials, I know the stakes are high for anyone relying on basic ingredients. Food security starts long before customers buy a packaged product; it begins with processing plants securing trustworthy supplies that meet global standards. Here, Shengtai’s premium product ensures that finished foods are safe, reliable, and consistent. In developing economies, affordable ingredients drive lower food costs and help improve access for low-income families. Stable pricing and high standards can reduce the risk of contamination or adulteration, which remain critical health risks in many parts of the world. For nutritionists and public health officials, knowing that basic ingredients can be traced back to reputable sources makes all the difference for consumer confidence. While global debates rage on about GMOs and chemical additives, Shengtai’s transparent quality assurance gives regulators and buyers peace of mind. In the past, a single tainted batch could force entire product recalls, costing millions and shaking public faith. By setting high benchmarks and willingly opening their doors to inspectors, Shengtai strengthens the entire supply chain.The reach of premium corn starch extends far past the kitchen or bakery. In an industrial context, this stuff acts as both a binder and a performance enhancer—crucial in everything from biodegradable plastics to pill coatings. Pharmaceutical companies depend on its purity when compounding medicines; paper producers count on its properties for smooth printing surfaces; even construction materials draw on its adhesive qualities. These applications demand not just raw material but a supplier willing to tweak formulations and respond to changing regulatory requirements. Shengtai’s dedicated research and development teams help companies adapt to consumer trends, such as plant-based diets and allergen-free foods. By keeping pace with scientific advances, Shengtai doesn’t just react to global shifts—they actively shape them. For example, their product development has supported new packaging types that reduce waste, driving both corporate responsibility and public good. By encouraging open dialogue with technical teams and academic partners, they’ve helped spark breakthroughs that ripple throughout global industries.Trust anchors every successful enterprise, especially in a globalized market where business deals often span continents and cultures. Shengtai’s direct approach to quality assurance and open communication with clients sets the company apart in a crowded market. Their willingness to undergo independent quality audits and maintain transparency gives importers the confidence to make long-term commitments. In an era where food fraud and supply chain opacity shake consumer faith, this kind of reliability holds immense value. Businesses gain by having fewer complications with customs clearances and faster product launches. For Shengtai, every satisfied repeat customer forms the basis for continued market leadership, proving that a commitment to excellence outlasts the latest market fad. Cleveland Clinic, for instance, has highlighted the importance of food ingredient traceability for patient safety, which holds even more weight in pharmaceutical applications. By putting quality ahead of cost-cutting, and relationships before short-term revenue, Shengtai demonstrates what responsible growth looks like in practice.Global businesses in the twenty-first century face a tangled web of logistical hurdles, rising costs, and sharp shifts in demand. Companies looking for a steady supply of essential inputs often find themselves juggling multiple suppliers, freight forwarders, and customs brokers. Shengtai’s footprint in the sector shows how vertical integration—in this case, managing both sourcing and logistics—simplifies these challenges. Direct relationships with shipping lines and knowledge of trade policies help keep deliveries on track. In times of crisis, this can mean the difference between a stalled assembly line and meeting an international deadline. Reliable producers create ripples throughout value chains, supporting jobs not only in primary processing but also in downstream industries from packing to retail. As countries tighten safety regulations and compliance costs rise, trusted suppliers reduce the risk of getting tangled up in bureaucratic red tape.For competitors and collaborators alike, Shengtai’s global leadership in corn starch offers a form of healthy pressure. Rivals paying attention see that investments in quality control, sustainable sourcing, and workforce training aren’t just PR strategies—they’re now entry points for participation in export markets. The ripple effect pushes other manufacturers to rethink business-as-usual and prioritize responsible growth. For policymakers, this means working more closely with industry leaders to strengthen sustainability incentives and invest in rural infrastructure. As digital traceability tools evolve, partnerships with companies like Shengtai reduce the knowledge gap separating fast-rising markets from established economies. Industry associations and standard-setting bodies also benefit from the data and best practices Shengtai shares, making it easier to roll out effective compliance programs and safety audits.Challenges remain. World demand for corn-based products is rising, and global agriculture faces pressure from climate change, land use changes, and commodity price volatility. Here’s where practical solutions come into focus. Continued investment in cleaner production facilities and innovative waste recycling systems has to rank high on every agenda. Working closely with farmers to encourage resilient crop strains helps buffer the risks from drought or pests. Transparency tools—like digital ledgers tracing every shipment—offer both peace of mind and leverage in regulatory negotiations. Collaboration between governments, academic institutions, and responsible producers paves the way for new benchmarks in safety and sustainability. These efforts will not only secure market share but support broader goals of food security, job creation, and resource conservation.
On December 11th, the sixth interview team of the "Talking Shandong Online" series of external publicity activities visited Weifang. Cui Hongbo, Deputy General Manager of Weifang Shengtai Medicine Co., Ltd., was interviewed by reporters, discussing how to bring corn to the world's dining tables and medicine bottles.As a group enterprise with corn deep processing as its core business, Shengtai Pharmaceutical has been in operation for over two decades, with products covering multiple fields such as pharmaceutical raw materials and food additives. In 2024, with its pharmaceutical glucose workshop obtaining FDA certification in the United States, the company's globalization process entered a new stage."International certification is not only an acknowledgment of quality, but also a 'passport' to open up different national markets," Cui Hongbo summarized the company's core strategy for "going global." Behind these seemingly simple words lies a precise and rigorous international certification and registration system built by Shengtai Pharmaceutical.System Certification Builds a Global Passport MatrixIn the pharmaceutical field, Shengtai Pharmaceutical has successively passed US DMF registration, EU CEP registration, Japanese JDMF registration, and pharmaceutical GMP certification, culminating in last year's acquisition of the most challenging US FDA certification. In the food sector, the company has built a complete system including FSSC22000, Indonesian BPJPH and international HALAL certification, KOSHER certification, IP and Non-GMO certification.“Each certificate is a precise response to the specific market regulations and cultural needs,” said Cui Hongbo. He explained that after the pharmaceutical glucose workshop obtained FDA certification, it not only consolidated its position in the US market but also generated a chain reaction, driving breakthroughs in markets such as Japan, South Korea, Europe, and South America. This certification matrix has earned Shengtai Pharmaceutical the trust of international customers. When products simultaneously possess multiple certifications such as Halal, Kosher, and Non-GMO, it means they can meet diverse needs from Southeast Asia to the Middle East, from North America to Europe, significantly enhancing the company's brand value.Dual-Engine Development of R&D and Market ExpansionIn Cui Hongbo's view, certifications are “passports,” while R&D strength is the “internal driving force” for the company to navigate the international market. Shengtai Pharmaceutical has two R&D centers in the east and west, and three provincial-level R&D platforms. 64% of the company's full-time R&D team holds master's degrees, and the company has attracted top talent, including three experts from the Taishan Talent Project. This team has compiled and registered 23 enterprise standards and obtained 64 authorized patents. In terms of market expansion, the company has formed a combined model of "exhibition-driven lead generation + on-site in-depth expansion." The Shengtai team can be seen at top international industry exhibitions such as CPHI World Pharmaceutical Ingredients Exhibition, FIC China International Food Additives Exhibition, Fi Europe, and the IFT exhibition in the United States."We adhere to the strategy of 'going out, going in, and connecting,'" Cui Hongbo explained. "Going out means participating in exhibitions, going in means visiting customers in person to understand their needs, and connecting means establishing long-term and stable cooperative relationships." This strategy has significantly improved the company's market expansion efficiency.Full-chain layout extending value from raw materials to end productsShengtai Pharmaceutical has built a complete industrial chain starting with corn. Its annual corn processing capacity of 700,000 tons is transformed into various products such as corn starch, modified starch, crystalline glucose, and liquid glucose. These products flow globally along two main lines: one to the pharmaceutical field, entering pharmaceutical production lines in various countries as raw materials and excipients; the other to the food field, appearing on the tables of consumers worldwide as food additives. The company's products are widely used in pharmaceuticals, food, papermaking, fine chemicals, and bioengineering, forming a cross-industry integrated product matrix. This full-chain layout enables the company to flexibly respond to changes in demand in different markets and occupy a favorable position in the global supply chain.Looking towards the "15th Five-Year Plan," Shengtai Pharmaceutical has planned three major construction projects: a 100,000-ton-per-year specialty corn starch project, a 150,000-ton-per-year premium starch sugar project, and the continued construction of the 220,000-ton-per-year high-end starch premix intelligent manufacturing project of Gerunmaier. These three projects represent a total investment of 900 million yuan and are expected to generate an additional 4.1 billion yuan in sales revenue. "These projects will open up new growth opportunities for us, especially in the high-end niche market," Cui Hongbo revealed.Today, Shengtai Pharmaceutical's cargo ships are sailing to more distant seaports, while on the production line in Weifang, deeply processed corn products are being packaged, ready to embark on a new international journey. From simple raw material exports to providing specialty products that meet the unique needs of various countries, Shengtai Pharmaceutical's overseas expansion demonstrates a principle: in the global market, only companies that respect differences, adapt to standards, and cultivate value can achieve steady and long-term success.
